医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Commitment to World Trade Center Victim Identification: 2021 International Symposium on Human Identification (ISHI) Spotlights 9/11 Response & Ongoing Advances

2021年08月11日 PM08:00
このエントリーをはてなブックマークに追加


 

MADISON, Wis.

The International Symposium on Human Identification (ISHI) September 13-16, the world’s largest annual meeting focusing on DNA forensics, will mark the 20th anniversary of the September 11th terrorist attacks in the United States. Keynote speaker Mark Desire, Assistant Director, New York City Office of the Chief Medical Examiner (OCME), will speak to the hardship and perseverance of OCME forensic scientists and families of World Trade Center victims, as well as ongoing work to identify all who lost their lives that day. A panel will also discuss advances in forensic science worldwide that have resulted from two decades of the 9/11 investigation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210811005075/en/

The 2021 International Symposium on Human Identification (ISHI) September 13-16 will mark the 20th anniversary of 9/11 with a keynote address from Mark Desire, Assistant Director, New York City Office of the Chief Medical Examiner (OCME). Desire will speak to ongoing work to identify all who lost their lives that day, as well as advances in forensic science worldwide that have resulted from two decades of the 9/11 investigation. ISHI is the world's largest annual meeting focusing on DNA forensics and has been sponsored by Promega Corporation for 32 years. (Graphic: Business Wire)

The 2021 International Symposium on Human Identification (ISHI) September 13-16 will mark the 20th anniversary of 9/11 with a keynote address from Mark Desire, Assistant Director, New York City Office of the Chief Medical Examiner (OCME). Desire will speak to ongoing work to identify all who lost their lives that day, as well as advances in forensic science worldwide that have resulted from two decades of the 9/11 investigation. ISHI is the world’s largest annual meeting focusing on DNA forensics and has been sponsored by Promega Corporation for 32 years. (Graphic: Business Wire)

WHAT: ISHI draws nearly 1000 law enforcement professionals and scientists from around the world to explore the latest developments in forensic DNA research, process and technique. Now in its 32nd year, ISHI has been witness to emerging technologies, changing policies and significant advances in forensics.

Along with the 9/11 keynote and panel discussion, ISHI32 will cover:

  • Rapid DNA technology
  • Forensic genetic genealogy (FGG)
  • Degraded DNA recovery
  • Virtual courtroom testimony
  • Protein sequencing for forensic analysis
  • Interpretation of Y chromosome STRs for missing persons cases

WHERE: Hybrid on-site/virtual format:

  • On-site: Coronado Springs Resort, Lake Buena Vista, Florida. Up to 750 attendees who must be fully vaccinated against COVID-19 and adhere to posted safety guidelines.
  • Virtual: Registrations available at a reduced rate.

WHEN: September 13-16, 2021

WHO: ISHI attracts an audience of forensic professionals representing 40+ countries and a variety of professions including criminalists, research scientists, lab directors, CODIS analysts and forensic scientists to discuss the latest advances in forensic DNA analysis. Media are invited to attend and must pre-register.

Promega Corporation, a leader in providing innovative solutions and technical support to the life sciences industry, including products for DNA-based human identification, has sponsored ISHI for 32 years.

WEB: Visit www.ishinews.com for agenda, registration and late-breaking updates.

About Promega Corporation

This symposium for forensic experts and suppliers is offered through Promega Corporation, a leader in providing innovative solutions and technical support to the life sciences industry. Promega Corporation has provided products for DNA-based human identification for more than 25 years. Promega is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 4,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210811005075/en/

CONTACT

Penny Patterson

VP, Corporate Affairs

Promega Corporation

Phone: (608) 274-4330

E-mail: penny.patterson@promega.com

同じカテゴリーの記事 

  • BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients
  • MRMヘルス、回腸嚢炎治療薬MH002の第2a相臨床試験で安全性と良好な有効性データを報告
  • KBIバイオファーマ、Jean-Baptiste Agnus氏を最高業務責任者(CBO)に指名
  • 佐賀大学とBostonGeneがEGFR陽性肺癌患者におけるICIの治療効果予測因子を特定するための新規バイオマーカー探索を目的とした研究を発表
  • KBI Biopharma任命Jean-Baptiste Agnus为首席商务官